PL3423072T3 - Kompozycje do leczenia kandydozy - Google Patents

Kompozycje do leczenia kandydozy

Info

Publication number
PL3423072T3
PL3423072T3 PL17707061.2T PL17707061T PL3423072T3 PL 3423072 T3 PL3423072 T3 PL 3423072T3 PL 17707061 T PL17707061 T PL 17707061T PL 3423072 T3 PL3423072 T3 PL 3423072T3
Authority
PL
Poland
Prior art keywords
compositions
treating candidiasis
candidiasis infections
infections
treating
Prior art date
Application number
PL17707061.2T
Other languages
English (en)
Inventor
Adrien NIVOLIEZ
Original Assignee
Nexbiome Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexbiome Therapeutics filed Critical Nexbiome Therapeutics
Publication of PL3423072T3 publication Critical patent/PL3423072T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL17707061.2T 2016-03-01 2017-03-01 Kompozycje do leczenia kandydozy PL3423072T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1651717A FR3048361B1 (fr) 2016-03-01 2016-03-01 Compositions pour le traitement des candidoses
PCT/EP2017/054701 WO2017148975A1 (fr) 2016-03-01 2017-03-01 Compositions pour le traitement des candidoses

Publications (1)

Publication Number Publication Date
PL3423072T3 true PL3423072T3 (pl) 2023-10-02

Family

ID=56411709

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17707061.2T PL3423072T3 (pl) 2016-03-01 2017-03-01 Kompozycje do leczenia kandydozy

Country Status (9)

Country Link
US (2) US11197899B2 (pl)
EP (1) EP3423072B1 (pl)
CN (1) CN109069557A (pl)
ES (1) ES2951677T3 (pl)
FR (1) FR3048361B1 (pl)
HU (1) HUE062933T2 (pl)
PL (1) PL3423072T3 (pl)
RU (1) RU2732244C2 (pl)
WO (1) WO2017148975A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107937324B (zh) * 2018-01-10 2020-01-21 中国科学院微生物研究所 一株卷曲乳杆菌及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
ATE207755T1 (de) * 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
US6479051B1 (en) 1998-12-11 2002-11-12 Urex Biotex, Inc. Oral administration of lactobacillus for the treatment and prevention of urogenital infection
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US20020044926A1 (en) 1999-12-10 2002-04-18 Gregor Reid Oral administration of lactobacillus for the treatment and prevention of urogenital infection
BR0111785A (pt) * 2000-06-19 2003-05-20 Candivax Pty Ltd Composições e métodos para tratamento de candidìase
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
WO2006045347A1 (en) 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
US8329447B2 (en) * 2008-12-12 2012-12-11 Osel, Inc. Strain of Lactobacillus crispatus
ITRM20110477A1 (it) * 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
FR2992861B1 (fr) * 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
FR3018193B1 (fr) * 2014-03-10 2017-09-08 Probionov Comprime vaginal muco-adhesif a liberation prolongee
BR112016031000B1 (pt) * 2014-07-01 2022-01-25 Probi USA, Inc. Forma de dosagem em camadas e método para fazer a mesma

Also Published As

Publication number Publication date
CA3012557A1 (fr) 2017-09-08
WO2017148975A1 (fr) 2017-09-08
RU2018132814A3 (pl) 2020-04-09
US20220125863A1 (en) 2022-04-28
CN109069557A (zh) 2018-12-21
RU2732244C2 (ru) 2020-09-14
BR112018067416A8 (pt) 2022-08-30
EP3423072B1 (fr) 2023-06-07
EP3423072C0 (fr) 2023-06-07
ES2951677T3 (es) 2023-10-24
EP3423072A1 (fr) 2019-01-09
RU2018132814A (ru) 2020-04-01
BR112018067416A2 (pt) 2018-12-26
US20190046593A1 (en) 2019-02-14
FR3048361B1 (fr) 2020-12-18
FR3048361A1 (fr) 2017-09-08
US11197899B2 (en) 2021-12-14
HUE062933T2 (hu) 2023-12-28

Similar Documents

Publication Publication Date Title
ZA201802719B (en) Treatment compositions providing an antimicrobial benefit
ZA201608604B (en) Compositions and methods for treating and preventing staphylococcus aureus infections
SG11201700621XA (en) Antibiotic compositions for treating bacterial infections
PT3215173T (pt) Composições de glicopéptidos
EP3324987A4 (en) Bacteriophage for treating staphylococcus infections
IL291266A (en) Preparations and methods for treating infections
GB201607814D0 (en) Anti-microbial compositions
IL265986A (en) Arsenic compounds
SMT202200261T1 (it) Composizioni per il trattamento dell’amiloidosi
GB201604249D0 (en) Improved hydrophilic compositions
GB201607699D0 (en) Anti-microbial compositions
ZA201706948B (en) Antibacterial compositions
IL256236B (en) Mannose derivatives for the treatment of bacterial infections
EP3212183A4 (en) Synergistic compositions for treating microbial infections
HUE062406T2 (hu) Készítmények szemészeti állapotok kezelésére
ZA201608407B (en) Stain treatment compositions
HUE062933T2 (hu) Candidiasis kezelésére szolgáló készítmények
PL3160263T3 (pl) Kompozycje do zapobiegania zakażeniom
GB201602658D0 (en) Compositions
ZA201903342B (en) An antimicrobial composition
ZA201706947B (en) Antibacterial compositions
IL249616A0 (en) Methods for treating inflammation
ZA201608405B (en) Stain treatment compositions
EP3242664A4 (en) Compositions and methods for treating gastrointestinal infections
PT3142749T (pt) Composição para viscossuplementação compreendendo ulvano para tratamento de artrite